文献速递中医内科中药与中成药合理使用

中药注射剂治疗新型冠状病毒肺炎的叙述性综述

Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review.
PubMed 文献 · Integr Med Res · 2021-09-30

本文通过检索PubMed、CNKI和Web of Science三个数据库,综述中药注射剂治疗COVID-19的疗效与安全性。有限数据显示中药注射剂联合常规治疗可改善临床结局,主要与缓解症状、预防继发感染、调节炎症和免疫功能相关,体外研究显示对SARS-CoV-2复制有抑制作用,但真实世界数据提示不良事件风险增加。

要点

  • 中药注射剂联合常规治疗可能改善COVID-19患者临床结局。
  • 获益主要与缓解症状、预防继发感染、调节炎症和免疫相关。
  • 真实世界数据提示中药注射剂不良事件风险增加。

核心结论

  • 中药注射剂如血必净注射液和生脉注射液对COVID-19表现出强效作用,但需进一步实验室研究和临床评估以收集疗效与安全性的科学证据。

研究设计与样本

  • 叙述性综述,检索PubMed、CNKI和Web of Science三个电子数据库,检索词包括COVID-19、SARS-CoV-2、traditional Chinese medicine、herb、herbal和injection,并对纳入文献进行全面评估。

主要发现

  • 有限数据表明中药注射剂可显著改善COVID-19患者临床结局,尤其与常规治疗联合时。
  • 获益主要与缓解症状、预防继发感染、调节炎症和免疫功能相关。
  • 有证据显示中药注射剂在体外对SARS-CoV-2复制有抑制作用。
  • 现有真实世界数据提示中药注射剂不良事件风险增加。

关键数值与推荐

  • 中药注射剂如血必净注射液和生脉注射液对COVID-19表现出强效作用。
  • 有限数据表明中药注射剂可显著改善COVID-19患者临床结局,尤其联合常规治疗时。
  • 真实世界数据提示中药注射剂不良事件风险增加。

临床怎么用

  • 中药注射剂可考虑联合常规治疗用于COVID-19以改善临床结局。
  • 使用中药注射剂时需关注不良事件风险增加。

局限性

  • 现有数据有限,需进一步实验室研究和临床评估以收集疗效与安全性的科学证据。
  • 现有研究存在缺陷。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The outbreak of Coronavirus disease 2019 (COVID-19) has caused more than 180 million infections and 3.9 million deaths. To date, emerging clinical evidence has shown the synergetic benefits of Chinese herbal injections in treating this contagious respiratory disease. This review aims to summarize and analyze the efficacy and safety of Chinese herbal injections in the therapy of COVID-19. METHODS: The literature from 3 electronic databases, PubMed, CNKI, and Web of Science, were searched using the search terms "COVID-19", "SARS-CoV-2", "traditional Chinese medicine", "herb", "herbal", and "injection". Then the identified articles were comprehensively evaluated. RESULTS: Limited data demonstrated that Chinese herbal injections could significantly improve the clinical outcomes of COVID-19 patients, especially in combination with conventional treatment strategies. The benefits of which were mainly associated with the relief of symptoms, prevention of secondary infection, regulation of inflammation and immune function. There was also evidence showing the inhibitory effects on SARS-CoV-2 replication in vitro. Nevertheless, available real-world data suggested the increased risk of adverse event. Furthermore, the defects of existing researches and the insights for discovering novel antiviral drugs were prospectively discussed. CONCLUSION: Evidence-based advances revealed that Chinese herbal injections such as XueBiJing injection and ShenMai injection, exerted potent effects against COVID-19. Further laboratory researches and clinical evaluation are needed to gather scientific evidence on the efficacy and safety.

来源:Integr Med Res,查看原文。版权归原作者所有。

引用

  1. Zhu XB, Guo M, Zhang ZH, et al. Chinese herbal injections for coronavirus disease 2019 (COVID-19): A narrative review. Integr Med Res. 2021. PMID: 34608432. doi:10.1016/j.imr.2021.100778

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。